Links

Tools

Export citation

Search in Google Scholar

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.

Journal article published in 2013 by Ra A. Eeles, Aa A. Olama, Ej J. Saunders, Da A. Leongamornlert, Malgorzata Tymrakiewicz, De E. Neal, Craig Luccarini, Loic Le Marchand, Ken Muir, Gianluca Severi, Fredrik Wiklund, Tj J. Key, Fredrick Schumacher, Rc C. Travis, Loic Le Marchand and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P < 5 × 10(-8)). More than 70 prostate cancer susceptibility loci, explaining ∼30% of the familial risk for this disease, have now been identified. On the basis of combined risks conferred by the new and previously known risk loci, the top 1% of the risk distribution has a 4.7-fold higher risk than the average of the population being profiled. These results will facilitate population risk stratification for clinical studies.